Patents by Inventor Aleksandar Radovanovic

Aleksandar Radovanovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of sickle cell disease
    Patent number: 10085967
    Abstract: The present invention includes embodiments for treatment and/or prevention of sickle cell disease that employ Hydroxyfasudil or Isocoronarin D alone or either in conjunction with each other or an inducer of HbF production. The compounds may act synergistically, and the compounds employed circumvent the side effects seen with Hydroxyurea.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: October 2, 2018
    Assignee: King Abdullah University of Science and Technology
    Inventors: Megbubah Essack, Vladimir Bajic, Aleksandar Radovanovic
  • TREATMENT OF SICKLE CELL DISEASE
    Publication number: 20170209412
    Abstract: The present invention includes embodiments for treatment and/or prevention of sickle cell disease that employ Hydroxyfasudil or Isocoronarin D alone or either in conjunction with each other or an inducer of HbF production. The compounds may act synergistically, and the compounds employed circumvent the side effects seen with Hydroxyurea.
    Type: Application
    Filed: April 10, 2017
    Publication date: July 27, 2017
    Inventors: Megbubah Essack, Vladimir Bajic, Aleksandar Radovanovic
  • Treatment of sickle cell disease
    Patent number: 9655905
    Abstract: The present invention includes embodiments for treatment and/or prevention of sickle cell disease that employ Hydroxyfasudil or Isocoronarin D alone or either in conjunction with each other or an inducer of HbF production. The compounds may act synergistically, and the compounds employed circumvent the side effects seen with Hydroxyurea.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: May 23, 2017
    Assignee: KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Magbubah Essack, Vladimir Bajic, Aleksandar Radovanovic
  • TREATMENT OF SICKLE CELL DISEASE
    Publication number: 20140356458
    Abstract: The present invention includes embodiments for treatment and/or prevention of sickle cell disease that employ Hydroxyfasudil or Isocoronarin D alone or either in conjunction with each other or an inducer of HbF production. The compounds may act synergistically, and the compounds employed circumvent the side effects seen with Hydroxyurea.
    Type: Application
    Filed: September 13, 2012
    Publication date: December 4, 2014
    Applicant: KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Magbubah Essack, Vladimir Bajic, Aleksandar Radovanovic